XI’AN, China, March 17, 2025 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a prominent provider of bio-ingredient solutions for the natural, health, and personal care sectors, announced the pricing of a best efforts offering of units, detailed below, aiming to raise $12 million in gross proceeds before deducting placement agent fees and other expenses.

The offering includes ordinary units (or pre-funded units as an alternative) consisting of 8,333,332 Class A ordinary shares (or pre-funded warrants instead of Class A ordinary shares for the pre-funded units), Series A Warrants to buy one Class A ordinary share at $1.44 each (the “Series A Warrants”), and Series B Warrants to buy Class A ordinary shares at $2.16 each (the “Series B Warrants,” and collectively with the Series A Warrants, the “Warrants”). Pre-funded warrants can be exercised immediately upon issuance and expire upon full exercise. The Warrants are immediately exercisable upon issuance and expire three years from the initial exercise date.

Each ordinary unit is priced at $1.44, while each pre-funded unit is priced at $1.439 (price minus $0.001).

The Company plans to allocate the net proceeds to expand its sales network, enhance research and development, increase production capacity, and for general corporate purposes, including working capital. The offering is expected to be finalized around March 18, 2025, pending standard closing conditions.

Univest Securities, LLC is the sole placement agent for this offering.

These securities are being offered by the Company through a registration statement on Form F-1 (File No. 333-283333), as amended, previously filed with and declared effective by the SEC. This press release is not an offer to sell or a solicitation of an offer to buy these securities, nor will any sale occur in any jurisdiction where such offer, solicitation, or sale is unlawful before registration or qualification under the securities laws of that jurisdiction. The offering is being conducted solely through a preliminary prospectus and a final prospectus that will be part of the registration statement. The final prospectus will be filed with the SEC and accessible on its website at www.sec.gov. Electronic copies of the final prospectus can be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.

About Bon Natural Life Limited

BON, based in the Cayman Islands, operates in the natural, health, and personal care sectors. More details are available at .

Forward-Looking Statements

This announcement contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements can be identified by terms like “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” and similar expressions. While the Company believes these forward-looking statements are reasonable, it cannot guarantee their accuracy and cautions investors that actual results may significantly differ. These statements are based on current beliefs, expectations, and assumptions regarding the Company’s future business, plans, strategies, projections, events, trends, the economy, regulatory activities, and other future conditions. Because they relate to the future, they are subject to uncertainties, risks, and changes, many of which are beyond the Company’s control. Therefore, undue reliance should not be placed on these statements. These risks include, among others: the completion of the offering, the satisfaction of customary closing conditions, the intended use of proceeds, BON’s limited operating history and historical losses; BON’s ability to raise additional funding; competition; BON’s ability to protect its intellectual property; and BON’s expectations regarding its growth, strategy, progress towards its goals. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. The Company undertakes no obligation to update forward-looking statements to reflect subsequent events or changes in expectations, except as required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact:

Cindy Liu | IR

Email: bonnatural@appchem.cn

“`